多种空气污染物对肌少症进展的影响:前瞻性队列的多状态分析
基于英国生物银行50381名基线无可能肌少症和肌少症的参与者,随访中位8.98年,4445人(8.8%)发生可能肌少症,17人(0.4%)进展为肌少症。多状态模型显示PM2.5、NO2和NOx增加肌少症进展及死亡风险,模拟同时降低4种污染物10%可降低15年累积风险。
要点
- PM2.5、NO2和NOx均增加可能肌少症及肌少症发生风险,并增加死亡风险。
- 模拟同时降低4种污染物10%可使15年累积风险降低(RR=0.93;RD=-2.21)。
- 性别、家庭收入和BMI对空气污染与肌少症进展的关联存在效应修饰。
核心结论
- 空气污染与肌少症进展风险增加相关,清洁空气对预防和延缓肌少症进展有重要作用。
研究设计与样本
- 基于英国生物银行前瞻性队列,纳入50381名基线无可能肌少症和肌少症的参与者。
- 采用多状态模型分析空气污染与肌少症进展的关联,并用参数化g计算模拟污染降低情景下的累积风险。
主要发现
- 中位随访8.98年,4445人(8.8%)发生可能肌少症,17人(0.4%)进展为肌少症。
- PM2.5增加可能肌少症(HR=1.06;95%CI 1.02-1.10)、肌少症(HR=1.18;95%CI 1.04-1.34)、基线至死亡(HR=1.11;95%CI 1.02-1.20)和可能肌少症至死亡(HR=1.24;95%CI 1.04-1.50)的风险。
- NO2增加可能肌少症(HR=1.06;95%CI 1.02-1.10)、肌少症(HR=1.23;95%CI 1.09-1.39)、基线至死亡(HR=1.10;95%CI 1.01-1.19)和可能肌少症至死亡(HR=1.23;95%CI 1.01-1.50)的风险。
- NOx增加可能肌少症(HR=1.06;95%CI 1.03-1.09)、肌少症(HR=1.15;95%CI 1.04-1.26)和可能肌少症至死亡(HR=1.22;95%CI 1.04-1.43)的风险。
- 模拟同时降低4种污染物10%可降低15年累积风险(RR=0.93;RD=-2.21)。
临床怎么用
- 在老年肌少症风险管理中,可将空气污染暴露纳入评估,尤其关注性别、家庭收入和BMI修饰效应下的易感人群。
- 强调清洁空气作为预防和延缓肌少症进展的公共卫生措施。
局限性
- 肌少症进展事件数较少(17例),可能限制统计效能。
- 暴露估计基于住宅地址,未考虑个体活动空间和时间加权。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Air pollution's influence on sarcopenia progression remains insufficiently studied. METHODS: Using the UK Biobank cohort, we included 50381 participants initially free of probable sarcopenia and sarcopenia. Exposures to PM2.5, PM10, PM2.5-10, NO2, and NOx for each transition stage were estimated at each participant's residential addresses using data from the UK's department. Parametric g-computation was applied to estimate cumulative risks under hypothetical pollution reduction scenarios. Multistate models were used to examine associations between air pollution and sarcopenia progression. RESULTS: During 8.98 years (median), 4445 (8.8%) participants developed probable sarcopenia; 17 (0.4%) progressed to sarcopenia. Parametric g-computation estimated that a simultaneous 10% reduction in all 4 pollutants would decrease the 15-year cumulative risk (risk ratio [RR] = 0.93; risk difference [RD] = -2.21). In multistate models, PM2.5 increased risks of probable sarcopenia (hazard ratio [HR]: 1.06; 95% confidence interval [CI]: 1.02-1.10), sarcopenia (HR: 1.18; 95% CI: 1.04-1.34), baseline to death (HR: 1.11; 95% CI: 1.02-1.20,) and probable sarcopenia to death (HR: 1.24; 95% CI: 1.04-1.50). NO2 showed similar associations: probable sarcopenia (HR: 1.06; 95% CI: 1.02-1.10), sarcopenia (HR: 1.23; 95% CI: 1.09-1.39), baseline to death (HR: 1.10; 95% CI: 1.01-1.19), and probable sarcopenia to death (HR: 1.23; 95% CI: 1.01-1.50). NOx increased risks for probable sarcopenia (HR: 1.06; 95% CI: 1.03-1.09), sarcopenia (HR: 1.15; 95% CI: 1.04-1.26), and probable sarcopenia to death (HR: 1.22; 95% CI: 1.04-1.43). Stratified analyses indicated effect modification by sex, household income, and body mass index (BMI). CONCLUSIONS: These findings highlight the critical role of clean air in preventing and delaying sarcopenia progression, especially in vulnerable populations.
引用
- Sang N, Dai X, Yang Q, et al. The influence of multiple air pollutants on sarcopenia progression: a multi-state analysis in a prospective cohort. J Gerontol A Biol Sci Med Sci. 2026. PMID: 41701152. doi:10.1093/gerona/glag052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。